宏基因组分析揭示房颤患者肠道菌群脂多糖合成功能富集
本研究为前瞻性横断面研究,纳入50例非瓣膜性房颤患者与50名遗传背景匹配的对照,采用宏基因组测序分析肠道菌群脂多糖合成相关基因。结果显示房颤患者肠道中参与脂多糖合成的KO、酶基因及物种显著富集,基于关键因子构建的评分模型识别房颤的AUC达0.940~0.972,中介分析提示脂多糖合成通路可能参与房颤发病。
要点
- 房颤患者肠道菌群中脂多糖合成相关KO、酶基因和物种显著富集。
- 基于KO、酶基因、物种评分的ROC曲线AUC分别为0.957、0.940、0.972。
- 脂多糖合成关键KO介导了关键细菌对房颤总效应的35.17%。
核心结论
- 房颤患者肠道内富集参与脂多糖合成的细菌,通过编码脂多糖合成酶基因上调脂多糖合成功能。
研究设计与样本
- 前瞻性横断面研究,纳入2016年3月至2018年12月首都医科大学附属北京朝阳医院50例非瓣膜性房颤患者和50名遗传背景匹配的体检对照。
- 收集临床基线资料和粪便样本,提取细菌DNA,采用Illumina Novaseq进行宏基因组测序。
- 基于测序数据分析KO、酶基因及物种丰度,采用LASSO筛选关键因子,并通过ROC曲线、PLS-SEM和logistic回归评价其作用。
主要发现
- 房颤组50例,年龄66.0(57.0,71.3)岁,男性32例(64%);对照组50名,年龄55.0(50.5,57.5)岁,男性41例(82%)。
- 有20个KO、7个脂多糖合成酶编码基因和89个同时编码9个脂多糖合成酶的物种在组间存在差异。
- LASSO筛选出5个KO、3个酶基因和9个物种为关键因子;富集于房颤组的包括2个KO(K02851和K00972)、3个酶基因(LpxH、LpxC和LpxK)及7个物种。
- ROC曲线分析显示KO、酶基因、物种评分识别房颤的AUC分别为0.957(95%CI:0.918~0.995)、0.940(95%CI:0.889~0.991)和0.972(95%CI:0.948~0.997)。
- PLS-SEM显示关键KO介导了关键细菌对房颤总效应的35.17%;多因素logistic回归显示KO分值绝对值增大与房颤风险增加相关(OR<0.001,95%CI:<0.001~0.021,P<0.001)。
临床怎么用
- 肠道菌群脂多糖合成相关基因特征可能作为房颤风险评估的潜在生物标志物,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the functional changes of key gut microbiota (GM) that produce lipopolysaccharide (LPS) in atrial fibrillation (AF) patients and to explore their potential role in the pathogenesis of AF. Methods: This was a prospective cross-sectional study. Patients with AF admitted to Beijing Chaoyang Hospital of Capital Medical University were enrolled from March 2016 to December 2018. Subjects with matched genetic backgrounds undergoing physical examination during the same period were selected as controls. Clinical baseline data and fecal samples were collected. Bacterial DNA was extracted and metagenomic sequencing was performed by using Illumina Novaseq. Based on metagenomic data, the relative abundances of KEGG Orthology (KO), enzymatic genes and species that harbored enzymatic genes were acquired. The key features were selected via the least absolute shrinkage and selection operator (LASSO) analysis. The role of GM-derived LPS biosynthetic feature in the development of AF was assessed by receiver operating characteristic (ROC) curve, partial least squares structural equation modeling (PLS-SEM) and logistic regression analysis. Results: Fifty nonvalvular AF patients (mean age: 66.0 (57.0, 71.3), 32 males(64%)) were enrolled as AF group. Fifty individuals (mean age 55.0 (50.5, 57.5), 41 males(82%)) were recruited as controls. Compared with the controls, AF patients showed a marked difference in the GM genes underlying LPS-biosynthesis, including 20 potential LPS-synthesis KO, 7 LPS-biosynthesis enzymatic genes and 89 species that were assigned as taxa harbored nine LPS-enzymatic genes. LASSO regression analysis showed that 5 KO, 3 enzymatic genes and 9 species could be selected to construct the KO, enzyme and species scoring system. Genes enriched in AF group included 2 KO (K02851 and K00972), 3 enzymatic genes (LpxH, LpxC and LpxK) and 7 species (Intestinibacter bartlettii、Ruminococcus sp. JC304、Coprococcus catus、uncultured Eubacterium sp.、Eubacterium sp. CAG:251、Anaerostipes hadrus、Dorea longicatena). ROC curve analysis revealed the predictive capacity of differential GM-derived LPS signatures to distinguish AF patients in terms of above KO, enzymatic and species scores: area under curve (AUC)=0.957, 95%CI: 0.918-0.995, AUC=0.940, 95%CI 0.889-0.991, AUC=0.972, 95%CI 0.948-0.997. PLS-SEM showed that changes in lipopolysaccharide-producing bacteria could be involved in the pathogenesis of AF. The key KO mediated 35.17% of the total effect of key bacteria on AF. After incorporating the clinical factors of AF, the KO score was positively associated with the significantly increased risk of AF (OR<0.001, 95%CI:<0.001-0.021, P<0.001). Conclusion: Microbes involved in LPS synthesis are enriched in the gut of AF patients, accompanied with up-regulated LPS synthesis function by encoding the LPS-enzymatic biosynthesis gene. 目的: 分析心房颤动(房颤)患者肠道菌群脂多糖合成功能的变化特点及其可能的作用。 方法: 本研究为前瞻性、横断面研究。选取2016年3月至2018年12月在首都医科大学附属北京朝阳医院住院的非瓣膜性房颤患者作为房颤组,并选取同期遗传背景匹配的体检者作为对照。收集所有研究对象的临床基线资料及粪便样本,提取肠道细菌DNA,采用Illumina novaseq进行宏基因组学测序。基于宏基因组学测序数据,分析脂多糖合成过程中的同源基因簇(KEGG orthology,KO)、合成酶的编码基因及含有这些酶基因的细菌的丰度。基于LASSO分析,筛选与房颤相关的参与脂多糖合成的关键因子,并采用受试者工作特征(ROC)曲线分析、中介分析和logistic回归分析评价其在房颤发病中可能的作用。 结果: 房颤组50例,年龄66.0(57.0,71.3)岁,男性32例(64%)。对照组50名,年龄55.0(50.5,57.5)岁,男性41例(82%)。有20个参与脂多糖合成的KO、7个脂多糖合成酶的编码基因和89个同时可编码9个脂多糖合成酶的肠道细菌在对照组与房颤组间存在差异。LASSO回归分析显示,有5个KO、3个酶基因及9个种层级物种被筛选为关键因子,其中富集在房颤组的因子包括:2个KO(K02851和K00972),3个酶基因(LpxH、LpxC和LpxK),7个种层级物种(Intestinibacter bartlettii、Ruminococcus sp. JC304、Coprococcus catus、uncultured Eubacterium sp.、Eubacterium sp. CAG:251、Anaerostipes hadrus、Dorea longicatena)。基于上述关键因子构建回归模型,ROC曲线分析示:KO、酶基因、物种分值识别房颤的曲线下面积(AUC)和95%CI分别为0.957(0.918~0.995)、0.940(0.889~0.991)和0.972(0.948~0.997)。中介分析的结果显示,参与脂多糖合成的肠道细菌的变化可影响房颤发病,其中有35.17%是通过富集相应的KO所介导。多因素logistic回归分析结果显示,KO分值绝对值增大,房颤的发生风险增加(OR值<0.001,95%CI:<0.001~0.021,P<0.001)。 结论: 房颤患者肠道内富集了参与脂多糖合成的细菌,其通过编码脂多糖合成酶基因,使得房颤患者脂多糖合成功能有所上调。.
引用
- Zuo K, Zhang J, Fang C, et al. [Metagenomic data-analysis reveals enrichment of lipopolysaccharide synthesis in the gut microbiota of atrial fibrillation patients]. Zhonghua Xin Xue Guan Bing Za Zhi. 2022. PMID: 35340143. doi:10.3760/cma.j.cn112148-20210106-00015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。